# Association Between Salivary Sirtuin-1 Levels and Periodontitis

**Authors:** Leonardo Lorente, Esther Hernández Marrero, Pedro Abreu González, Angel Daniel Lorente Martín, Marina Lorente Martín, María José Marrero González, Carmen Hernández Marrero, Olga Hernández Marrero, Alejandro Jiménez, Cándido Manuel Hernández Padilla

PMC · DOI: 10.3390/jcm15041485 · 2026-02-13

## TL;DR

This study found that low levels of SIRT-1 in saliva may be linked to periodontitis and could help in its diagnosis, though more research is needed.

## Contribution

The study is the largest to date on salivary SIRT-1 levels in periodontitis and explores its diagnostic potential.

## Key findings

- Salivary SIRT-1 concentrations below 1.2 ng/mL were independently associated with periodontitis.
- Salivary SIRT-1 showed a 74% accuracy in diagnosing periodontitis.
- Low SIRT-1 levels may serve as a supplementary diagnostic marker for periodontitis.

## Abstract

Background: Sirtuin-1 (SIRT-1) is one enzyme that has anti-oxidative, anti-inflammation and anti-apoptosis effects, and it is involved in regulating aging and in different age-associated disorders. Salivary SIRT-1 concentrations in periodontitis patients have been scarcely studied and only in studies with small sample sizes (the highest with 83 subjects). There were no differences in salivary SIRT-1 concentrations between periodontitis patients and periodontally healthy subjects in any of those studies. The aims of our study were to compare salivary SIRT-1 concentrations in subjects with periodontitis and those without it in a study with a larger sample size to determine whether there exists an association between salivary SIRT-1 concentrations and the presence of periodontitis and to analyze the potential capability of salivary SIRT-1 concentrations for periodontitis diagnosis. Material and Methods: In this cross-sectional study, salivary SIRT-1 concentrations were measured in subjects with and without periodontitis. To determine that variables were associated with periodontitis, a multivariate logistic regression analysis was carried out. To determine the capability of salivary SIRT-1 concentrations to diagnose periodontitis, a receiver operating characteristic (ROC) analysis was carried out. Results: We included 144 subjects (85 without periodontitis and 59 with periodontitis). Salivary SIRT-1 concentrations < 1.2 ng/mL were associated independently with periodontitis (OR = 2.84; 95% CI = 1.075–7.506; p = 0.04) in the regression analysis. The salivary SIRT-1 concentration showed an area under curve of 74% (95% CI = 66–86%; p < 0.001) for periodontitis diagnosis in the ROC analysis. Conclusions: Our study had the highest sample size reporting salivary SIRT-1 concentrations in patients with periodontitis. We found that low salivary SIRT-1 concentrations could be associated with the presence of periodontitis. In addition, they could play a role in periodontitis diagnosis as an adjunct to other markers given that their diagnostic capability is not high. However, given the limitations of our study, further investigations are necessary to confirm these preliminary findings.

## Linked entities

- **Proteins:** SIRT1 (sirtuin 1), SIRT1 (sirtuin 1)
- **Diseases:** periodontitis (MONDO:0005076)

## Full-text entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, Sirt1 (sirtuin 1) [NCBI Gene 309757] {aka Sir2}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, SIRT4 (sirtuin 4) [NCBI Gene 23409] {aka SIR2L4}, SIRT7 (sirtuin 7) [NCBI Gene 51547] {aka SIR2L7}, SIRT2 (sirtuin 2) [NCBI Gene 22933] {aka SIR2, SIR2L, SIR2L2}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, SIRT6 (sirtuin 6) [NCBI Gene 51548] {aka SIR2L6, hSIRT6}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, BCL2L11 (BCL2 like 11) [NCBI Gene 10018] {aka BAM, BIM, BOD}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}
- **Diseases:** tooth loss (MESH:D016388), apical periodontitis (MESH:D010485), rheumatoid arthritis (MESH:D001172), injury to (MESH:D014947), gingival inflammation (MESH:D007249), Periodontitis (MESH:D010518), hypertension (MESH:D006973), diabetes mellitus (MESH:D003920), cancer (MESH:D009369), cardiovascular disease (MESH:D002318), swelling (MESH:D004487), bone loss (MESH:D001847), gingivitis (MESH:D005891), hypercholesterolemia (MESH:D006937), oral diseases (MESH:D009059), obesity (MESH:D009765), bleeding (MESH:D006470), oral candidiasis (MESH:D002180), liver, kidney, cardiovascular, brain, bowel and lung diseases (MESH:C567034), dental fluorosis (MESH:D009050), tumorigenesis (MESH:D063646), oral cancer (MESH:D009062), pulpitis (MESH:D011671), bone resorption (MESH:D001862), erythema (MESH:D004890), herpesvirus infections (MESH:D006566), periodontal pockets (MESH:D010514), systemic lupus erythematosus (MESH:D008180)
- **Chemicals:** ELT-11c (-), superoxide (MESH:D013481), oxygen (MESH:D010100), SRT1460 (MESH:C525424), Ex-527 (MESH:C550547), SRT1720 (MESH:C525422), uric acid (MESH:D014527), cambinol (MESH:C510718), nitrites (MESH:D009573), 3,3',5,5'-tetramethylbenzidine (MESH:C021758), malondialdehyde (MESH:D008315), SRT2104 (MESH:C584666), adenosine diphosphate (MESH:D000244), methotrexate (MESH:D008727), metformin (MESH:D008687), manganese dioxide (MESH:C016552), SirReal2 (MESH:C000609012), water (MESH:D014867), SRT3025 (MESH:C000601293), 3-nitrotyrosine (MESH:C002744), alcohol (MESH:D000438), Resveratrol (MESH:D000077185), NAD (MESH:D009243), ROS (MESH:D017382), SRT2183 (MESH:C525423), H2SO4 (MESH:C033158), 8-hydroxydeoxyguanosine (MESH:D000080242), piceatannol (MESH:C041525)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Arachis hypogaea (goober, species) [taxon 3818], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12941437/full.md

---
Source: https://tomesphere.com/paper/PMC12941437